Page 914 - Robbins Basic Pathology by Vinay Kumar, Abul K. Abbas, Jon C. Aster

900 Index in the immunocompromised host
cytomegalovirus infections and 500–501
Plasma protein-derived mediator pneumocystis pneumonia and 501–502
coagulation and Kinin system as 51–52 as pulmonary infection 500–502
complement system as 50–51, 50f
summary for 52b Pneumonia (P. jiroveci)
HIV infections and 151, 151t, 313
Plasminogen activator inhibitor (PAI) 80, 85f
Platelet Pneumonia, chronic
nontuberculous mycobacterial disease as 499
activation of 80, 82 as pulmonary infection 492–499
adhesion and 82 tuberculosis and 493–498
aggregation of 82
discussion of 81–82 Pneumonia, cryptogenic organizing 473–474, 474f
endothelial interaction with 81f, 82 Pneumonia, hospital-acquired 491–492
normal hemostasis and 80f Pneumothorax 511
normal hemostasis and 79 Podocyte injury 522f, 523, 528
summary for 82b Poliovirus 828
Platelet-activating factor (PAF) 47–48 Pollution, environmental
Platelet activation 82, 82b
Platelet adherence 79 air pollution as 272–273
Platelet adhesion 80f–81f, 82 industrial/agricultural exposures as 276–277
Platelet aggregation 81f, 82, 82b metals as 273–276
Platelet contraction 82 Polyarteritis nodosa (PAN)
Pleiotropy 218–219 autoimmune diseases and 135
Pleomorphic undifferentiated sarcoma 794 clinical features of 352
Pleomorphic adenoma 163, 556–557, 557f morphology of 352b, 352f
morphology of 556b–557b vasculitis and 352
Pleomorphic fibroblastic sarcoma 794, 794f Polycystic kidney disease, autosomal recessive
Pleomorphism 165, 165f clinical course of 544
Pleural effusion 511 cystic diseases and 544
Pleural lesion morphology of 544b
of the lungs 511–512 summary for 544
malignant mesothelioma as 512 Polycystic ovarian disease 695–696
pleural effusion and pleuritis as 511 Polycythemia 425, 425t
pneumothorax, hemothorax, chylothorax as Polycythemia vera
as chronic myeloproliferative disorder 447
511–512 clinical course of 447–448
Pleuritis 511 morphology of 447b
Plexiform neurofibroma 807, 808b Polymerase chain reaction (PCR) analysis 264–266, 266f
Plummer syndrome 728b Polymerase chain reaction (PCR) analysis
Pneumoconiosis molecular diagnosis and 211
Polymorphism
asbestosis as 477 complex multigenic disorders and 234
coal worker’s pneumoconiosis as 475 genetic abnormalities and 216–217
as fibrosing disease 474–478, 474t linkage analysis and 245–246
mineral dust and 277 P-450 enzymes and 271–272
pathogenesis of 474b–475b Polymyositis 805, 806f
silicosis as 476 Polyneuritis multiplex 798
summary for 478b Polyneuropathy 798
Pneumocystis pneumonia Polyomavirus 828–829
in the immunocompromised host 501–502 Polyp, endometrial 693
morphology of 502b, 502f Polyp, hamartomatous
Pneumonia colonic polyps and 592–593, 593t, 600
caused by other pathogens juvenile polyps as 592
Peutz-Jeghers syndrome as 592–593
Haemophilus influenzae as 489 Polyp, inflammatory
Klebsiella pneumoniae as 489–490 colonic polyps as 592, 600
Legionella pneumophila as 490 gastric polyps and 569, 572
Moraxella catarrhalis as 489
Pseudomonas aeruginosa as 490 morphology of 569b
Staphylococcus aureus as 489 Polyp, juvenile 592
community-acquired acute
morphology of 488b, 489f morphology of 592b, 594f
pneumonias caused by other important pathogens Polyp, nomenclature for 162, 163f
Polypoid cystitis (ureter) 668
and 488–490 Portal hypertension
as pulmonary infection 486–490
streptococcus pneumoniae infections as 487–488 ascites and 609
community-acquired atypical liver disease and 608–609, 609f
clinical features of 490–491 Portal vein obstruction/thrombosis 632–634
influenza infections as 491 Portopulmonary hypertension 610
influenza virus type A/HINI infection as 491 Port wine stain 357
morphology of 490b, 491f Posterior fossa anomaly 823
as pulmonary infections 490–491 Posterior pituitary syndrome 721
summary for 491b